Light therapy could offer new option for prostate cancer patients

NCT ID NCT06807359

Recruiting now Disease control Sponsor: SpectraCure AB Source: ClinicalTrials.gov ↗

First seen Jan 06, 2026 · Last updated May 16, 2026 · Updated 18 times

Summary

This early-stage study tests a new treatment for prostate cancer that hasn't spread. It uses a special light-sensitive drug and laser fibers placed into the prostate to destroy cancer cells. About 43 men will take part, and researchers will check safety and how well the treatment works over 18 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Klinik für Urologie, Universitätsklinikum Köln
RECRUITING

Cologne, 50937, Germany

Contact
Klinik und Poliklinik für Urologie, Universitätsmedizin Rostock
RECRUITING

Rostock, Germany

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••
Memorial Sloan Kettering Cancer Center
RECRUITING

New York, New York, 10065, United States

Contact

Conditions

Explore the condition pages connected to this study.

PROSTATE CANCER